Allosteric regulation of GRB2 modulates RAS activation

References

• McKay M, Morrison D. Integrating signals from RTKs to ERK/MAPK. Oncogene. 2007;26(22):3113–3121.
   PubMed Web of Science ®Google Scholar
• Nakhaei-Rad S, Haghighi F, Nouri P, et al. Structural fingerprints, interactions, and signaling networks of RAS family proteins beyond RAS isoforms. Crit Rev Biochem Mol Biol. 2018;53(2):130–156.
   PubMed Web of Science ®Google Scholar
• Tartaglia M, Gelb BD. Disorders of dysregulated signal traffic through the RAS‐MAPK pathway: phenotypic spectrum and molecular mechanisms. Ann N Y Acad Sci. 2010;1214(1):99–121.
   PubMedGoogle Scholar
• Dhillon AS, Hagan S, Rath O, et al. MAP kinase signalling pathways in cancer. Oncogene. 2007;26(22):3279–3290.
   PubMed Web of Science ®Google Scholar
• Castel P, Rauen KA, McCormick F. The duality of human oncoproteins: drivers of cancer and congenital disorders. Nat Rev Cancer. 2020;20(7):383–397.
   PubMed Web of Science ®Google Scholar
• Hebron KE, Hernandez ER, Yohe ME. The RASopathies: from pathogenetics to therapeutics. Dis Model Mech. 2022;15(2):dmm049107.
   PubMed Web of Science ®Google Scholar
• Awad MM, Liu S, Rybkin II, et al. Acquired Resistance to KRASG12C Inhibition in Cancer. N Engl J Med. 2021;384(25):2382–2393.
   PubMed Web of Science ®Google Scholar
• Pudewell S, Ahmadian MR. Spotlight on accessory proteins: RTK-RAS-MAPK modulators as new therapeutic targets. Biomolecules. 2021;11(6):895.
   PubMed Web of Science ®Google Scholar
• Pudewell S, Wittich C, Kazemein Jasemi NS, et al. Accessory proteins of the RAS-MAPK pathway: moving from the side line to the front line. Commun Biol. 2021;4(1):1–10.
   PubMed Web of Science ®Google Scholar
• Neumann K, Oellerich T, Urlaub H, et al. The B‐lymphoid Grb2 interaction code. Immunol Rev. 2009;232(1):135–149.
   PubMedGoogle Scholar
• Ijaz M, Wang F, Shahbaz M, et al. The role of Grb2 in cancer and peptides as Grb2 antagonists. Protein Pept Lett. 2017;24(12):1084–1095.
   Web of Science ®Google Scholar
• Giubellino A, Burke TR, Bottaro DP. Grb2 signaling in cell motility and cancer. Expert Opin Ther Targets. 2008;12(8):1021–1033.
   PubMed Web of Science ®Google Scholar
• Rozakis-Adcock M, McGlade J, Mbamalu G, et al. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 1992;360(6405):689–692.
   PubMed Web of Science ®Google Scholar
• Ahmed Z, Timsah Z, Suen KM, et al. Grb2 monomer–dimer equilibrium determines normal versus oncogenic function. Nat Commun. 2015;6(1):1–11.
   Google Scholar
• Rozakis-Adcock M, Fernley R, Wade J, et al. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature. 1993;363(6424):83–85.
   PubMed Web of Science ®Google Scholar
• Gong Q, Cheng AM, Akk AM, et al. Disruption of T cell signaling networks and development by Grb2 haploid insufficiency. Nat Immunol. 2001;2(1):29–36.
   PubMed Web of Science ®Google Scholar
• McDonald CB, Seldeen KL, Deegan BJ, et al. Assembly of the Sos1–Grb2–Gab1 ternary signaling complex is under allosteric control. Arch Biochem Biophys. 2010;494(2):216–225.
   PubMed Web of Science ®Google Scholar
• Lowenstein E, Daly RJ, Batzer AG, et al. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell. 1992;70(3):431–442.
   PubMed Web of Science ®Google Scholar
• Dharmawardana PG, Peruzzi B, Giubellino A, et al. Molecular targeting of growth factor receptor-bound 2 (Grb2) as an anti-cancer strategy. Anticancer Drugs. 2006;17(1):13–20.
   PubMed Web of Science ®Google Scholar
• Simon JA, Schreiber SL. Grb2 SH3 binding to peptides from Sos: evaluation of a general model for SH3-ligand interactions. Chem Biol. 1995;2(1):53–60.
   PubMedGoogle Scholar
• Mayer BJ, Baltimore D. Signalling through SH2 and SH3 domains. Trends Cell Biol. 1993;3(1):8–13.
   PubMedGoogle Scholar
• Pawson T, Schlessingert J. SH2 and SH3 domains. Curr Biol. 1993;3(7):434–442.
   PubMed Web of Science ®Google Scholar
• Dionne U, Bourgault É, Dubé AK, et al. Protein context shapes the specificity of SH3 domain-mediated interactions in vivo. Nat Commun. 2021;12(1):1–15.
   PubMed Web of Science ®Google Scholar
• Schlessinger J, Lemmon MA. SH2 and PTB domains in tyrosine kinase signaling. Science’s STKE. 2003;2003(191):re12–re12.
   PubMedGoogle Scholar
• Bisson N, James DA, Ivosev G, et al. Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor. Nat Biotechnol. 2011;29(7):653–658.
   PubMed Web of Science ®Google Scholar
• Zhou S, Shoelson SE, Chaudhuri M, et al. SH2 domains recognize specific phosphopeptide sequences. Cell. 1993;72(5):767–778.
   PubMed Web of Science ®Google Scholar
• Lewitzky M, Kardinal C, Gehring NH, et al. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical PxxP core motif. Oncogene. 2001;20(9):1052–1062.
   PubMed Web of Science ®Google Scholar
• Oehrl W, Kardinal C, Ruf S, et al. The germinal center kinase (GCK)-related protein kinases HPK1 and KHS are candidates for highly selective signal transducers of Crk family adapter proteins. Oncogene. 1998;17(15):1893–1901.
   PubMed Web of Science ®Google Scholar
• Welch NG, Li W, Hossain MA, et al. (Re) Defining the proline-rich antimicrobial peptide family and the identification of putative new members. Front Chem. 2020;8:1157.
   Web of Science ®Google Scholar
• Elias RD, Ma W, Ghirlando R, et al. Proline-rich domain of human ALIX contains multiple TSG101-UEV interaction sites and forms phosphorylation-mediated reversible amyloids. Proc Nat Acad Sci. 2020;117(39):24274–24284.
   PubMed Web of Science ®Google Scholar
• Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997;9(2):180–186.
   PubMed Web of Science ®Google Scholar
• Reuther GW, Der CJ. The Ras branch of small GTPases: ras family members don’t fall far from the tree. Curr Opin Cell Biol. 2000;12(2):157–165.
   PubMed Web of Science ®Google Scholar
• McDonald CB, El Hokayem J, Zafar N, et al. Allostery mediates ligand binding to Grb2 adaptor in a mutually exclusive manner. J Mol Recog. 2013;26(2):92–103.
   PubMed Web of Science ®Google Scholar
• Montagner A, Yart A, Dance M, et al. A novel role for Gab1 and SHP2 in epidermal growth factor-induced Ras activation. J Biol Chem. 2005;280(7):5350–5360.
   PubMed Web of Science ®Google Scholar
• Egan SE, Giddings BW, Brooks MW, et al. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature. 1993;363(6424):45–51.
   PubMed Web of Science ®Google Scholar
• Li NA, Batzer A, Daly R, et al. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature. 1993;363(6424):85–88.
   PubMed Web of Science ®Google Scholar
• Lemmon MA, Ladbury JE, Mandiyan V, et al. Independent binding of peptide ligands to the SH2 and SH3 domains of Grb2. J Biol Chem. 1994;269(50):31653–31658.
   PubMed Web of Science ®Google Scholar
• Cussac D, Frech M, Chardin P. Binding of the Grb2 SH2 domain to phosphotyrosine motifs does not change the affinity of its SH3 domains for Sos proline‐rich motifs. EMBO J. 1994;13(17):4011–4021.
   PubMed Web of Science ®Google Scholar
• Houtman JC, Yamaguchi H, Barda-Saad M, et al. Oligomerization of signaling complexes by the multipoint binding of GRB2 to both LAT and SOS1. Nat Struct Mol Biol. 2006;13(9):798–805.
   PubMed Web of Science ®Google Scholar
• Bartelt RR, Light J, Vacaflores A, et al. Regions outside of conserved PxxPxR motifs drive the high affinity interaction of GRB2 with SH3 domain ligands. Biochim Biophys Acta-Mol Cell Res. 2015;1853(10):2560–2569.
   Web of Science ®Google Scholar
• Sastry L, Lin W, Wong WT, et al. Quantitative analysis of Grb2-Sos1 interaction: the N-terminal SH3 domain of Grb2 mediates affinity. Oncogene. 1995;11(6):1107–1112.
   PubMed Web of Science ®Google Scholar
• McDonald CB, Seldeen KL, Deegan BJ, et al. SH3 domains of Grb2 adaptor bind to PXpsiPXR motifs within the Sos1 nucleotide exchange factor in a discriminate manner. Biochemistry. 2009;48(19):4074–4085.
   PubMed Web of Science ®Google Scholar
• McDonald CB, Seldeen KL, Deegan BJ, et al. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1. Arch Biochem Biophys. 2008;479(1):52–62.
   PubMed Web of Science ®Google Scholar
• Innocenti M, Tenca P, Frittoli E, et al. Mechanisms through which Sos-1 coordinates the activation of Ras and Rac. J Cell Biol. 2002;156(1):125–136.
   PubMed Web of Science ®Google Scholar
• Liao T-J, Jang H, Nussinov R, et al. High-Affinity Interactions of the nSH3/cSH3 domains of Grb2 with the C-Terminal proline-rich domain of SOS1. J Am Chem Soc. 2020;142(7):3401–3411.
   PubMed Web of Science ®Google Scholar
• Liao T-J, Jang H, Fushman D, et al. SOS1 interacts with Grb2 through regions that induce closed nSH3 conformations. J Chem Phys. 2020;153(4):045106.
   PubMed Web of Science ®Google Scholar
• Tari AM, Lopez-Berestein G. GRB2: a pivotal protein in signal transduction. Semin Oncol. 2001;28(5 Suppl 16):142–147.
   PubMed Web of Science ®Google Scholar
• Kazemein Jasemi NS, Herrmann C, Magdalena Estirado E, et al. The intramolecular allostery of GRB2 governing its interaction with SOS1 is modulated by phosphotyrosine ligands. Biochem J. 2021;478(14):2793–2809.
   PubMed Web of Science ®Google Scholar
• McDonald CB, Bhat V, Kurouski D, et al. Structural landscape of the proline-rich domain of Sos1 nucleotide exchange factor. Biophys Chem. 2013;175-176:54–62.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Gupta R, Mayer BJ. Differential inhibition of signaling pathways by dominant-negative SH2/SH3 adapter proteins. Mol Cell Biol. 1995;15(12):6829–6837.
   PubMed Web of Science ®Google Scholar
• Beigbeder A, Chartier FJM, Bisson N. MPZL1 forms a signalling complex with GRB2 adaptor and PTPN11 phosphatase in HER2-positive breast cancer cells. Sci Rep. 2017;7(1):11514.
   PubMedGoogle Scholar
• Watanabe T, Shinohara N, Moriya K, et al. Significance of the Grb2 and son of sevenless (Sos) proteins in human bladder cancer cell lines. IUBMB Life. 2000;49(4):317–320.
   PubMed Web of Science ®Google Scholar
• Laursen L, Kliche J, Gianni S, et al. Supertertiary protein structure affects an allosteric network. Proc Natl Acad Sci U S A. 2020;117(39):24294–24304.
   PubMed Web of Science ®Google Scholar
• Stock G, Hamm P. A non-equilibrium approach to allosteric communication. Philos Trans R Soc Lond B Biol Sci. 2018;373(1749):20170187.
   PubMed Web of Science ®Google Scholar
• Gunasekaran K, Ma B, Nussinov R. Is allostery an intrinsic property of all dynamic proteins? Proteins. 2004;57(3):433–443.
   PubMed Web of Science ®Google Scholar
• Malagrino F, Troilo F, Bonetti D, et al. Mapping the allosteric network within a SH3 domain. Sci Rep. 2019;9(1):8279.
   PubMedGoogle Scholar
• Park M-J, Sheng R, Silkov A, et al. SH2 domains serve as lipid-binding modules for pTyr-Signaling PROTEINS. Mol Cell. 2016;62(1):7–20.
   PubMed Web of Science ®Google Scholar